Emerging Biopharma

Shield soldier knight armour sword
Biotech

Braveheart, with Biogen CEO on board, rallies $185M series A

The biotech is led by former HI-Bio founder and CEO Travis Murdoch, M.D., while Biogen's CEO Chris Viehbacher chairs the board of directors.
Zoey Becker Nov 5, 2025 7:51am
Close up of pink azalea flowers

In vivo gene editing biotech blossoms from Jennifer Doudna's lab

Nov 4, 2025 8:00am
Man looks at rocket launch

Neok exits stealth with $75M to take bispecific ADCs into clinic

Nov 4, 2025 7:00am
Closeup of blue eye on black background

Italian biotech raises $141M series B to fund eye gene therapies

Nov 3, 2025 3:00am
ZigZag zigging zagging

Zag Bio emerges with $80M funding for Tregs diabetes candidate

Oct 28, 2025 7:00am
AI drug discovery

Flagship brings AI drug discovery firm Expedition out of stealth

Oct 22, 2025 8:25am
More News

British biotech elevates with $70M and midstage arthritis asset

Oct 21, 2025 7:01pm

Excellergy emerges with $70M and ex-Dermavant CEO at the helm

Oct 13, 2025 10:50am

ARPA-H goes all in on in vivo cell therapy

Oct 8, 2025 4:04pm

Nilo launches with $101M and mission to harness neural circuits

Oct 8, 2025 9:55am